The clonal evolution of metastases from primary serous epithelial ovarian cancers

被引:54
|
作者
Khalique, Lalarukh [1 ]
Ayhan, Ayse [2 ,3 ]
Whittaker, John C. [4 ]
Singh, Naveena [5 ]
Jocobs, Ian J. [1 ]
Gayther, Simon A. [1 ]
Ramus, Susan J. [1 ]
机构
[1] UCL, Gynaecol Canc Res Labs, UCL EGA, Inst Womens Hlth, London WC1E 6BT, England
[2] Hacettepe Univ, Fac Med, Dept Pathol, TR-06100 Ankara, Turkey
[3] Seirei Mikatahara Hosp, Dept Pathol, Hamamatsu, Shizuoka, Japan
[4] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England
[5] Dept Pathol, London, England
关键词
ovarian cancer; genetic analysis; metastasis; clonal evolution; maximum parsimony; high-grade serous histology; BREAST-CANCER; GENETIC-HETEROGENEITY; PARALLEL EVOLUTION; UNIFOCAL ORIGIN; TUMORS; CELLS; HETEROZYGOSITY; PROGRESSION; CARCINOMA; TUMORIGENESIS;
D O I
10.1002/ijc.24148
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Several models of evolution from primary cancers to metastases have been proposed; but the most widely accepted is the clonal evolution model proposed for colorectal cancer in which tumors develop by a process of linear clonal evolution driven by the accumulation of somatic genetic alterations. Various other models of cancer progression and metastasis have been proposed, including parallel evolution and the same gene model. The aim of this study was to investigate the evolution of metastases from primary cancer in 22 patients diagnosed with high-grade serous epithelial ovarian cancer. We established somatic genetic profiles based on the pattern of loss of heterozygosity, in several different regions of tumor tissue within the primary tumor and metastatic deposits front each case. Maximum parsimony tree analysis was used to examine the evolutionary relationship between the primary and metastatic samples for each patient. In addition, we investigated the extent of genetic heterogeneity within and between metastatic tumors compared with primary ovarian tumors. Our data suggest that most, if not all, metastases are clonally related to the primary tumors. However, the data oppose a single model of linear-clonal evolution whereby a late stage clone within the primary tumor acquires additional genetic changes that enable metastatic progression. Instead, the data support a model in which primary ovarian cancers have a common clonal origin, but become polyclonal, with different clones at both early and late stages of genetic divergence acquiring the ability to progress to metastasis. (C) 2008 Wiley-Liss, Inc.
引用
收藏
页码:1579 / 1586
页数:8
相关论文
共 50 条
  • [21] Immunohistochemical profiles in primary lung cancers and epithelial pulmonary metastases
    Vidarsdottir, Halla
    Tran, Lena
    Nodin, Bjorn
    Jirstrom, Karin
    Planck, Maria
    Jonsson, Per
    Mattsson, Johanna S. M.
    Botling, Johan
    Micke, Patrick
    Brunnstrom, Hans
    HUMAN PATHOLOGY, 2019, 84 : 221 - 230
  • [22] Proteomic analyses of serous and endometrioid epithelial ovarian cancers - Cases studies - Molecular insights of a possible histological etiology of serous ovarian cancer
    Longuespee, Remi
    Gagnon, Hugo
    Boyon, Charlotte
    Strupat, Kurstin
    Dauly, Claire
    Kerdraon, Olivier
    Ighodaro, Adesuwa
    Desmons, Annie
    Dupuis, Jocelyn
    Wisztorski, Maxence
    Vinatier, Denis
    Fournier, Isabelle
    Day, Robert
    Salzet, Michel
    PROTEOMICS CLINICAL APPLICATIONS, 2013, 7 (5-6) : 337 - 354
  • [23] Functional Polymorphisms in the TERT Promoter Are Associated with Risk of Serous Epithelial Ovarian and Breast Cancers
    Beesley, Jonathan
    Pickett, Hilda A.
    Johnatty, Sharon E.
    Dunning, Alison M.
    Chen, Xiaoqing
    Li, Jun
    Michailidou, Kyriaki
    Lu, Yi
    Rider, David N.
    Palmieri, Rachel T.
    Stutz, Michael D.
    Lambrechts, Diether
    Despierre, Evelyn
    Lambrechts, Sandrina
    Vergote, Ignace
    Chang-Claude, Jenny
    Nickels, Stefan
    Vrieling, Alina
    Flesch-Janys, Dieter
    Wang-Gohrke, Shan
    Eilber, Ursula
    Bogdanova, Natalia
    Antonenkova, Natalia
    Runnebaum, Ingo B.
    Doerk, Thilo
    Goodman, Marc T.
    Lurie, Galina
    Wilkens, Lynne R.
    Matsuno, Rayna K.
    Kiemeney, Lambertus A.
    Aben, Katja K. H.
    Marees, Tamara
    Massuger, Leon F. A. G.
    Fridley, Brooke L.
    Vierkant, Robert A.
    Bandera, Elisa V.
    Olson, Sara H.
    Orlow, Irene
    Rodriguez-Rodriguez, Lorna
    Cook, Linda S.
    Le, Nhu D.
    Brooks-Wilson, Angela
    Kelemen, Linda E.
    Campbell, Ian
    Gayther, Simon A.
    Ramus, Susan J.
    Gentry-Maharaj, Aleksandra
    Menon, Usha
    Ahmed, Shahana
    Baynes, Caroline
    PLOS ONE, 2011, 6 (09):
  • [24] Screening and Identification of Biomarkers in Ascites Related to Intrinsic Chemoresistance of Serous Epithelial Ovarian Cancers
    Huang, He
    Li, Yujie
    Liu, Jihong
    Zheng, Minghui
    Feng, Yanling
    Hu, Kunhua
    Huang, Yongwen
    Huang, Qidan
    PLOS ONE, 2012, 7 (12):
  • [25] Serous ovarian, fallopian tube and primary peritoneal cancers: A comparative epidemiological analysis
    Jordan, Susan J.
    Green, Adle C.
    Whiteman, David C.
    Moore, Suzanne P.
    Bain, Christopher J.
    Gertig, Dorota M.
    Webb, Penelope M.
    INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (07) : 1598 - 1603
  • [26] Frequency and Distribution of Lymph Node Metastases in Epithelial Ovarian Cancer Significance of Serous Histology
    Haller, Herman
    Mamula, Ozren
    Krasevic, Maja
    Rupcic, Stanislav
    Fischer, Alemka Brncic
    Eminovic, Senija
    Manestar, Miljenko
    Perovic, Danko
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2011, 21 (02) : 245 - 250
  • [27] Brain metastases from epithelial ovarian carcinoma
    Kaminsky-Forrett, MC
    Weber, B
    Conroy, T
    Spaëth, D
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2000, 10 (05) : 366 - 371
  • [28] Brain metastases from epithelial ovarian cancer
    Tay, SK
    Rajesh, H
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2005, 15 (05) : 824 - 829
  • [29] MESOTHELIN EXPRESSION IN PRIMARY EPITHELIAL OVARIAN TUMORS AND INTRAPERITONEAL METASTASES
    Fraszczak, K.
    Barczynski, B.
    Tarkowski, R.
    Ziober-Malinowska, P.
    Kulak, K.
    Bobinski, M.
    Sobstyl, M.
    Polak, G.
    Bednarek, W.
    Kotarski, J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 634 - 634
  • [30] DETECTION OF ANDROGEN RECEPTOR INCIDENCE IN GYNAECOLOGICAL CANCERS AND ITS RELEVANCE IN HIGH GRADE SEROUS EPITHELIAL OVARIAN CANCERS
    Anjum, M. I.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A117 - A117